Business Services Industry
Baker Hughes' Manipulates Reported Revenue At Its Largest Business Unit, Says the Pomerantz Firm and Law Office of Klari Neuwelt
Business Wire, Jan 21, 2000
NEW YORK--(BUSINESS WIRE)--Jan. 21, 2000
The following is an announcement by the law firm of Pomerantz Haudek Block Grossman &Gross LLP:
Baker Hughes, Inc. (&uot;Baker Hughes&uot; or the &uot;Company&uot;) (NYSE:BHI) and two of the Company's senior officers allegedly manipulated reported revenue at the Company's largest business unit - INTEQ - in order to give the market the appearance that Baker Hughes was experiencing positive earnings growth while the opposite was occurring. Baker Hughes overstated the INTEQ drilling unit's earnings and included the overstatement into the Company's consolidated financial statements in violation of Generally Accepted Accounting Principles, according to allegations in a complaint filed by Pomerantz Haudek Block Grossman &Gross LLP (www.pomerantzlaw.com) and the Law Office of Klari Neuwelt on behalf of all those who purchased the common stock of Baker Hughes during the period between May 3, 1999 and December 8, 1999, inclusive (the &uot;Class Period&uot;).
As a result of the Company's actions, Baker Hughes' common stock was artificially inflated during the Class Period. The market first learned of Baker Hughes' misrepresentations on December 8, 1999, when it announced that it planned to restate its prior financial statements and postpone a $200 million note offering. As a result of the news, the price of Baker Hughes common stock lost more than 50% of its value.
If you purchased Baker Hughes common stock during the Class Period, you have until February 7, 2000 to ask the Court to appoint you as one of the lead plaintiffs for the Class. In order to serve as lead plaintiff, you must meet certain legal requirements. If you wish to discuss this action or have any questions, please contact Andrew G. Tolan, Esq. of the Pomerantz firm at 888-476-6529 (or (888) 4-POMLAW), toll free, or at agtolan@pomlaw.com by e-mail. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
The Pomerantz firm is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz firm pioneered the field of securities class actions. Today, over 50 years later, the Pomerantz firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion dollar damages awards on behalf of class members. The Law Office of Klari Neuwelt also has substantial experience in similar litigation.
CONTACT: Andrew G. Tolan, Esq. of Pomerantz Haudek Block Grossman &Gross LLP, 888- 476-6529 ((888) 4-POMLAW) or agtolan@pomlaw.com
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


